Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NXT629 is a selective and competitive antagonist of PPAR-α(human PPARα with an IC50 of 77 nM).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
5 mg | 約6-8 週間 | ¥ 134,500 |
25 mg | 約6-8 週間 | ¥ 383,500 |
50 mg | 約6-8 週間 | ¥ 500,500 |
100 mg | 約6-8 週間 | ¥ 643,000 |
説明 | NXT629 is a selective and competitive antagonist of PPAR-α(human PPARα with an IC50 of 77 nM). |
ターゲット&IC50 | PPARγ (human):15 μM, GR:32.5 μM, ERβ:15.2 μM, PPARδ (human):6 μM, PPARα (human):77 nM |
分子量 | 609.78 |
分子式 | C35H39N5O3S |
CAS No. | 1454925-59-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 125 mg/mL (204.99 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NXT629 1454925-59-7 Endocrinology/Hormones Estrogen/progestogen Receptor NXT 629 NXT-629 Inhibitor inhibitor inhibit